000 01325 a2200349 4500
005 20250516191724.0
264 0 _c20140414
008 201404s 0 0 eng d
022 _a1879-0852
024 7 _a10.1016/j.ejca.2013.12.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGonzalez-Martin, Antonio
245 0 0 _aUpdated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer).
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_cMar 2014
300 _a862-3 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOvarian Neoplasms
_xdrug therapy
700 1 _aGladieff, Laurence
700 1 _aTholander, Bengt
700 1 _aStroyakovsky, Daniel
700 1 _aGore, Martin
700 1 _aScambia, Giovanni
700 1 _aOaknin, Ana
700 1 _aSneller, Vesna
700 1 _aFreudensprung, Ulrich
700 1 _aPignata, Sandro
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 50
_gno. 4
_gp. 862-3
856 4 0 _uhttps://doi.org/10.1016/j.ejca.2013.12.001
_zAvailable from publisher's website
999 _c23443619
_d23443619